Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease.

Read full text
Authors: Louis John Kolling, Nagalakshmi Balasubramanian, Shafa Ismail, Alexander James Feller, Jessica Marie Hunter Alberhasky, Ruixiang Wang, Luke Jennings, Marco Hefti, Catherine Anne Marcinkiewcz
Cited by: 1
References: 75

Abstract

INTRODUCTION: Our previous studies demonstrate that htau mice recapitulate many of the neuropsychiatric features of early Alzheimer's disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate the vulnerability of the centromedial DRN to pathologically phosphorylated tau (p-tau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS: We use a battery of computational, molecular, biophysical, and behavioral techniques to assess molecular changes in the centromedial DRN across preclinical and post mortem settings. RESULTS: The centromedial DRN contains 5HT/glut neurons that differentially express ion-channel genes in the htau mouse. This is associated with increased neuronal excitability, which may promote p-tau accumulation. At Braak II, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to p-tau compared to 5HT-nonglut neurons. DISCUSSION: Tau-mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of p-tau in Braak progression.

Fields of Study & Subjects

Alzheimer's disease research and treatments Cholinesterase and Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Research

Publication details

Journal / source
PubMed
Publisher
Wiley
Volume
22
Issue
5
Pages
e71317–e71317
Publication date
1 May 2026
Language
EN